We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Should You Buy Experian plc, AVEVA Group plc & Oxford Instruments plc On Today’s Results?

Is it time to load up on Experian plc (LON:EXPN), AVEVA Group plc (LON:AVV) and Oxford Instruments plc (LON:OXIG)?

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The market has responded positively to results today from FTSE 100 firm Experian (LSE: EXPN), mid cap Aveva (LSE: AVV) and smaller company Oxford Instruments (LSE: OXIG).

In mid-morning trading the companies’ shares are up 6%, 4% and 5%, respectively. Could the time be ripe to buy a slice of these three stocks?

Should you buy Aveva Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Experian

Global information services group Experian — probably familiar to most readers as a consumer credit score firm — is a FTSE 100 blue chip, valued at £12bn based on a current share price of 1,170p.

In today’s half-year results, Experian posted a 6% fall in revenue from continuing operations, and a 7% fall in underlying earnings per share (EPS), reflecting foreign exchange headwinds during the period. However, at constant exchange rates revenue was up 4% and underlying EPS rose 5%.

Experian reported “good growth momentum” in the business, and full-year EPS should be helped by today’s news that the company is extending a $600m share buyback programme by a further $200m as it recycles proceeds from recent non-core divestments.

A full-year EPS outturn of 60p may be achievable. That’s a little above the analyst consensus ahead of today’s results, but still leaves Experian on a highish price-to-earnings (P/E) ratio of 19.5. The dividend yield is only modest at 2.2%, so the stock does not appear particularly cheap at the present time.

Aveva

Engineering software company Aveva also reported currency headwinds in the first half of the year. However, even at constant exchange rates, revenue was marginally down year-on-year, while profit before tax dived 20%. The reason is that Aveva has significant customers in the struggling oil & gas sector.

Given the heavy de-rating of companies exposed to this sector — either directly or indirectly — you may be surprised to learn that Aveva, with its shares currently trading at 2,085p, is on a sky-high current-year forecast P/E of 28, with a prospective dividend yield of just 1.4%.

However, Aveva — a FTSE 250 firm, valued at £1.3bn — has agreed to acquire Schneider Software to create “a global leader in industrial software”. The deal, a reverse takeover, would give Schneider Software’s parent (Schneider Electric) a 53.5% ownership of the enlarged Aveva.

The parties to this complex deal have been working towards finalising due diligence since July. Aveva said today that they expect to reach definitive terms in December, with completion anticipated to occur by mid-2016. I find it hard to put a value on Aveva at present, and to weigh up the potential risks and rewards, but City analysts are largely positive, rating the stock as either a Buy or a Hold.

Oxford Instruments

Last year was disappointing for Oxford Instruments, which supplies high technology tools and systems for industry and research. Macro headwinds in Japan and Russia, and weaker trading than expected in the company’s Industrial Analysis business, took their toll, and EPS fell 29%.

This year is looking brighter, with the company today reporting an uptick of 2% in first-half EPS, and a 21% rise in the order book since the start of the year. Margins have improved, as the group addresses its cost base, and management is confident the performance for the full year will be in line with expectations.

EPS of above 50p is expected by the City, giving an attractive-looking P/E of 12 at a share price of 605p. This smaller company — currently valued at around £350m — was rated considerably higher by the market not so long ago. I see the shares as very buyable at their present level, with the business looking set to return to growth.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

Hot, hotter, hottest. Is it too late to consider these 3 FTSE 100 shares?

James Beard looks at the three best- performing FTSE 100 stocks over the past year. But are they still worth…

Read more »

Young female analyst working at her desk in the office
Investing Articles

The only FTSE 100 stock I own right now

Muhammad Cheema reveals the only share he owns in the FTSE 100. However, that doesn’t mean he’s not a fan…

Read more »

Investing Articles

Are Greggs shares about to go gangbusters all over again?

Greggs shares have been showing signs of renewed life and Harvey Jones examines whether the battered FTSE 250 bakery chain…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

4,898 shares in British American Tobacco return £12,000 a year in dividends. Worth it?

A falling share price means a higher dividend yield for British American Tobacco shares. Should passive income investors take a…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Growth Shares

As it swallows up more firms, this penny stock looks primed to head higher

Jon Smith reviews a penny stock that has caught his attention, with its acquisition strategy proving to help increase the…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

£5,000 invested in HSBC shares in an ISA 5 years ago is now worth…

HSBC has made for a stunning investment. Andrew Mackie assesses whether new ISA investors could still see similar returns over…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

This UK income stock yields an eye-popping 7.3% but can it afford to keep growing its dividend?

Harvey Jones examines an income stock with a sky-high yield, because he wants to be sure it can keep the…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Is the best still to come for Rolls-Royce shares?

Christopher Ruane explains why he thinks Rolls-Royce shares could yet push even higher from here -- and whether he's ready…

Read more »